[1]
Sylvester Ndimele et al. 2022. Integrated Risk Assessment Coupled with Molecular Detection Platform Enhance Personalized Health Care in Metabolic Disorders. Emerging Trends in Disease and Health Research Vol. 3. (Feb. 2022), 94–101. DOI:https://doi.org/10.9734/bpi/etdhr/v3/1913A.